Shape Coding for Hearing Loss

Nashville, TN

N/A

Waitlist Available

Research Sponsored by Vanderbilt University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Must not have

Evidence of severe motor impairment (i.e., insufficient motor skills to complete eligibility evaluation tasks independently)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up begins no more than 2 weeks after intervention phase ends; lasts up to 3 weeks

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to improve the literacy skills of children who are deaf and hard of hearing by using a method called shape coding, which has been successful in teaching sentence structure in spoken English to children with language

See full description

Who is the study for?

This trial is for children in grades 5-8 who are deaf or hard of hearing. It aims to improve their written English sentence construction skills using shape coding, a visual support intervention.Check my eligibility

What is being tested?

The study tests the effectiveness of shape coding on improving accuracy in word order for written English sentences among deaf and hard of hearing children. The research involves single case studies with each participant being observed individually.See study design

What are the potential side effects?

Since this intervention is educational and not medical, there are no direct physical side effects like those associated with medication. However, participants may experience varying levels of engagement or frustration.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I struggle with severe motor skills issues, making it hard for me to complete tasks on my own.

show original

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ begins no more than 2 weeks after intervention phase ends; lasts up to 3 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~begins no more than 2 weeks after intervention phase ends; lasts up to 3 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and begins no more than 2 weeks after intervention phase ends; lasts up to 3 weeks for reporting.